Meeting
2022 ASCO Annual Meeting
Survival and prognostic factors in oligometastatic breast cancer.
Authors
Annemiek Van Ommen - Nijhof
The Netherlands Cancer Institute, Amsterdam, Netherlands
Annemiek Van Ommen - Nijhof , Tessa Gerjanne Steenbruggen , Laura C. Capel , Michel J.P. Vergouwen , Marie-Jeanne T.F.D Vrancken Peeters , Terry G. Wiersma , Gabe S. Sonke
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 1089)
DOI
10.1200/JCO.2022.40.16_suppl.1089
Abstract #
1089
Poster Bd #
466
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Rhabdomyosarcoma in the first year of life. outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
First Author: Monika Sparber-Sauer
Poster
2018 Gastrointestinal Cancers Symposium
Relationship between ethnicity and overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S).
First Author: Daniel E. Meyers
Poster
2024 ASCO Gastrointestinal Cancers Symposium
De novo metastatic versus recurrent gastroesophageal cancer: A single-centre retrospective analysis.
First Author: Abdul Rehman Farooq
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: A propensity score matched study.
First Author: Michael Yan